Jennifer L. Santos

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 812 citations · Full text

Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas

Martin Köbel, Steve E. Kalloger, David G. Huntsman et al. · International Journal of Gynecological Pathology · 2010 · 395 citations

Tumoral Pathology, Gynecological Surgery, Ovarian Carcinomas +10

Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer

Yinghui Guan, Wen-Lin Kuo, Jackie L. Stilwell et al. · Clinical Cancer Research · 2007 · 346 citations · Full text

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma

Steffen Böhm, Asma Faruqi, Ian Said et al. · Journal of Clinical Oncology · 2015 · 291 citations

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

C. Blake Gilks, Diana N. Ionescu, Steve E. Kalloger et al. · Human Pathology · 2008 · 238 citations

Tumoral Pathology, Tumor Cell Type, Medicine +8